ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Saturday, 21 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Adverse Business Impact

Sudeep Pharma Adverse Business Impact

GPCB directed closure of subsidiary Sudeep Nutrition's Vadodara plant under the Water Act for wastewater violations. All other units remain operational with no anticipated financial impact.

Source

BSE filing, NSE: SUDEEPPHRM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Sudeep Pharma Ltd: key numbers

Share price
₹1,191.50
Market cap
₹13,458 Cr
Revenue (annual)
₹642.3 Cr
Net profit (annual)
₹172.9 Cr
P/E (TTM)
71.5×Sector 49.0×
Promoter holding
76.15%+0.00% QoQ
FII holding
2.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sudeep Pharma Ltd

All →
12:31 IST BSE
Capacity Expansion

Sudeep Pharma Capacity Expansion

Sudeep Pharma received FDA approval for its new 51,200 MT greenfield plant at Nandesari, Gujarat. Commercial operations are expected to commence in H2 FY27 following customer qualification.

manufacturing capacity
51200 MT

Other adverse business impact announcements

All →